Publications by authors named "Josef Molnar"

Claim this Profile
D
Discovery of a novel class of small-molecule antibacterial agents against .
David Kreutzer, Robin Gehrmann, Annámaria Kincses, Nikoletta Szemerédi, Gabriella Spengler

Future Med Chem· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristic CT features of pheochromocytomas - probability model calculation tool based on a multicentric study.
Filip Ctvrtlik, Zbynek Tudos, Paulina Szasz, Zuzana Sedlackova, Igor Hartmann, Josef Molnar

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 9,10-Dihydroacridines as Novel Class of ABCB1 Inhibitors.
Andreas Hilgeroth, Marc Hemmer, Sebastian Neuber, Josef Molnár, Hermann Lage

Med Chem· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel structurally varied N-alkyl 1,4-dihydropyridines as ABCB1 inhibitors: structure-activity relationships, biological activity and first bioanalytical evaluation.
Andreas Hilgeroth, Christiane Baumert, Claudius Coburger, Marianne Seifert, Sören Krawczyk

Med Chem· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of small-molecule P-gp inhibitors of the N-benzyl 1,4-dihydropyridine type: novel aspects in SAR and bioanalytical evaluation of multidrug resistance (MDR) reversal properties.
Christiane Baumert, Marianne Günthel, Sören Krawczyk, Marc Hemmer, Tom Wersig

Bioorg Med Chem· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of pyridine-2-ones as novel class of multidrug resistance (MDR) modulators: first structure-activity relationships.
Sören Krawczyk, Monika Otto, Alexander Otto, Claudius Coburger, Martin Krug

Bioorg Med Chem· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidrug resistance reversal properties and cytotoxic evaluation of representatives of a novel class of HIV-1 protease inhibitors.
Claudius Coburger, Hermann Lage, Joséf Molnár, Andreas Langner, Andreas Hilgeroth

J Pharm Pharmacol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel structure-activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulators.
Claudius Coburger, Jörg Wollmann, Martin Krug, Christiane Baumert, Marianne Seifert

Bioorg Med Chem· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First biological evaluation of developed 3-benzyloxyfluorenes as novel class of MDR modulators.
Martin Krug, Burkhardt Voigt, Christiane Baumert, Ralf Lüpken, Joséf Molnár

Eur J Med Chem· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of novel MDR modulators on human cancer cells: reversal activities and induction studies.
Claudius Coburger, Hermann Lage, Josef Molnár, Andreas Hilgeroth

Pharm Res· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel insight in structure-activity relationship and bioanalysis of P-glycoprotein targeting highly potent tetrakishydroxymethyl substituted 3,9-diazatetraasteranes.
Claudius Coburger, Jörg Wollmann, Christiane Baumert, Martin Krug, Josef Molnár

J Med Chem· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P-glycoprotein effects of cyclic urea HIV protease inhibitor DMP 323 in competitional absorption studies.
Martin Richter, Nóra Gyémánt, Joséf Molnár, Andreas Hilgeroth

Arch Pharm (Weinheim)· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological evaluation of bishydroxymethyl-substituted cage dimeric 1,4-dihydropyridines as a novel class of p-glycoprotein modulating agents in cancer cells.
Martin Richter, Jósef Molnár, Andreas Hilgeroth

J Med Chem· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of calculated molecular orbital energies of some phenothiazine compounds with MDR reversal properties.
Andreas Hilgeroth, Annamária Molnár, Josef Molnár, Burkhardt Voigt

Eur J Med Chem· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First insight into the symmetry and flexibility of membrane efflux pump P-glycoprotein by novel bifunctional modulators.
Jörg Wollmann, Martin Richter, Jósef Molnár, Andreas Hilgeroth

Chembiochem· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effects on intestinal absorption in situ by P-glycoprotein-modifying HIV protease inhibitors.
Martin Richter, Nóra Gyémánt, Joséf Molnár, Andreas Hilgeroth

Pharm Res· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the first cytostatically active 1-aza-9-oxafluorenes as novel selective CDK1 inhibitors with P-glycoprotein modulating properties.
Kristin Brachwitz, Burkhardt Voigt, Laurent Meijer, Olivier Lozach, Christoph Schächtele

J Med Chem· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using molecular symmetry to form new drugs: hydroxymethyl-substituted 3,9-diazatetraasteranes as the first class of symmetric MDR modulators.
Andreas Hilgeroth, Jósef Molnár, Eric De Clercq

Angew Chem Int Ed Engl· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis